Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors
- Name
- Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors
- Accession Number
- DBCAT001940
- Description
Not Available
- Drugs
Drug Drug Description Idelalisib An antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). AZD-6482 AZD-6482 is under investigation in clinical trial NCT00688714 (Study to Investigate Safety and Tolerability of a Single Dose of AZD6482). - Drugs & Drug Targets